{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T04:00:03Z","timestamp":1773806403598,"version":"3.50.1"},"reference-count":31,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2018,7,9]]},"abstract":"<jats:p>We describe a case of an adult with dermatomyositis (DM) who presents with a rash, high fevers, tachycardia and hypotension, initially concerning for an infectious aetiology or a DM flare. She was found to have cytomegalovirus viraemia which improved after starting valganciclovir. After extensive workup and lack of improvement with broad-spectrum antimicrobial therapy, intravenous immunoglobulin and steroids, the patient was diagnosed with macrophage activation syndrome after bone marrow biopsy and levels of soluble CD25 (soluble interleukin (IL)-2 receptor) and IL2 were obtained. Unfortunately, despite therapy with dexamethasone, anakinra and etoposide, the patient decompensated and the patient\u2019s family opted for comfort care. The patient subsequently expired in the intensive care unit.<\/jats:p>","DOI":"10.1136\/bcr-2018-225231","type":"journal-article","created":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T13:20:28Z","timestamp":1532956828000},"page":"bcr-2018-225231","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Fatal case of macrophage activation syndrome (MAS) in a patient with dermatomyositis and cytomegalovirus (CMV) viraemia"],"prefix":"10.1136","volume":"2018","author":[{"given":"Allison Virginia","family":"Lange","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salahuddin","family":"Kazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weina","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arti","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,7,30]]},"reference":[{"key":"2025042705441934000_2018.jul27_1.bcr-2018-225231.1","unstructured":"Atteritano M , David A , Bagnato G , et al . Haemophagocytic syndrome in rheumatic patients. A systematic review 2012:1414\u201324."},{"key":"2025042705441934000_2018.jul27_1.bcr-2018-225231.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61048-X"},{"key":"2025042705441934000_2018.jul27_1.bcr-2018-225231.3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1684\/ejd.2011.1280","article-title":"Relationship between cytomegalovirus reactivation and dermatomyositis","volume":"21","author":"Kanetaka","year":"2011","journal-title":"Eur J Dermatol"},{"key":"2025042705441934000_2018.jul27_1.bcr-2018-225231.4","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0152"},{"key":"2025042705441934000_2018.jul27_1.bcr-2018-225231.5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00134-015-4066-9","article-title":"Cytomegalovirus reactivation in ICU patients","volume":"42","author":"Papazian","year":"2016","journal-title":"Intensive Care Med"},{"key":"2025042705441934000_2018.jul27_1.bcr-2018-225231.6","doi-asserted-by":"publisher","DOI":"10.1159\/000093640"},{"key":"2025042705441934000_2018.jul27_1.bcr-2018-225231.7","first-page":"232470961668451","article-title":"Hemophagocytic lymphohistiocytosis in a patient with hodgkin lymphoma and concurrent ebv, cmv, and candida infections","volume":"5","author":"Mustafa Ali","year":"2017","journal-title":"J Investig Med High Impact Case Rep"},{"key":"2025042705441934000_2018.jul27_1.bcr-2018-225231.8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.semarthrit.2015.07.004","article-title":"Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies","volume":"45","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"2025042705441934000_2018.jul27_1.bcr-2018-225231.9","first-page":"e1070","article-title":"Acute cytomegalovirus (CMV) infection associated with hemophagocytic lymphohistiocytosis (hlh) in an immunocompetent host meeting all eight hlh 2004 diagnostic criteria","volume":"9","author":"Bonnecaze","year":"2017","journal-title":"Cureus"},{"key":"2025042705441934000_2018.jul27_1.bcr-2018-225231.10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1556\/EuJMI.3.2013.1.12","article-title":"Cytomegalovirus associated haemophagocytic lymphohistiocytosis in the immunocompetent adult managed according to HLH-2004 diagnostic using clinical and serological means only","volume":"3","author":"Atim-Oluk","year":"2013","journal-title":"Eur J Microbiol Immunol"},{"key":"2025042705441934000_2018.jul27_1.bcr-2018-225231.11","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21008"},{"key":"2025042705441934000_2018.jul27_1.bcr-2018-225231.12","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken342"},{"key":"2025042705441934000_2018.jul27_1.bcr-2018-225231.13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.reuma.2014.06.007","article-title":"Secondary macrophage activation syndrome due to autoimmune, hematologic, infectious and oncologic diseases. Thirteen case series and review of the literature","volume":"11","author":"Eg\u00fces Dubuc","year":"2015","journal-title":"Reumatol Clin"},{"key":"2025042705441934000_2018.jul27_1.bcr-2018-225231.14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/bjh.13837","article-title":"Haemophagocytic lymphohistiocytosis in adults: a multicentre case series over 7 years","volume":"172","author":"Schram","year":"2016","journal-title":"Br J Haematol"},{"key":"2025042705441934000_2018.jul27_1.bcr-2018-225231.15","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1200\/JCO.2001.19.10.2665","article-title":"Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis","volume":"19","author":"Imashuku","year":"2001","journal-title":"J Clin Oncol"},{"key":"2025042705441934000_2018.jul27_1.bcr-2018-225231.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2011.01.027"},{"key":"2025042705441934000_2018.jul27_1.bcr-2018-225231.17","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21039"},{"key":"2025042705441934000_2018.jul27_1.bcr-2018-225231.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2004.12.016"},{"key":"2025042705441934000_2018.jul27_1.bcr-2018-225231.19","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1002\/art.38769","article-title":"Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"66","author":"Dav\u00ec","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2025042705441934000_2018.jul27_1.bcr-2018-225231.20","first-page":"481","article-title":"2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a european league against rheumatism\/american college of rheumatology\/paediatric rheumatology international trials organisation collaborative initiative","volume":"75","author":"Ravelli","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2025042705441934000_2018.jul27_1.bcr-2018-225231.21","doi-asserted-by":"crossref","unstructured":"Bazan-Socha S , Zolcinski M , Szostek M , et al . A fatal case of acquired hemophagocytic lymphohistiocytosis (macrophage activation syndrome) in the initial course of dermatomyositis with anti-Jo-1 antibody. Int J Rheum Dis 2017;20.doi:10.1111\/1756-185X.12162","DOI":"10.1111\/1756-185X.12162"},{"key":"2025042705441934000_2018.jul27_1.bcr-2018-225231.22","doi-asserted-by":"crossref","unstructured":"Yoshimatsu Y , Kotani T , Fujiki Y , et al . Successful treatment with intravenous high-dose immunoglobulin for cardiomyopathy in dermatomyositis complicated with rapid progressive interstitial pneumonia. Int J Rheum Dis 2015:n\/a.doi:10.1111\/1756-185X.12746","DOI":"10.1111\/1756-185X.12746"},{"key":"2025042705441934000_2018.jul27_1.bcr-2018-225231.23","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.10.1157"},{"key":"2025042705441934000_2018.jul27_1.bcr-2018-225231.24","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21564"},{"key":"2025042705441934000_2018.jul27_1.bcr-2018-225231.25","first-page":"21","article-title":"Sensitivity and specificity of bone marrow hemophagocytosis in hemophagocytic lymphohistiocytosis","volume":"42","author":"Goel","year":"2012","journal-title":"Ann Clin Lab Sci"},{"key":"2025042705441934000_2018.jul27_1.bcr-2018-225231.26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s12185-015-1813-1","article-title":"Evaluating the optimal serum ferritin level to identify hemophagocytic lymphohistiocytosis in the critical care setting","volume":"102","author":"Saeed","year":"2015","journal-title":"Int J Hematol"},{"key":"2025042705441934000_2018.jul27_1.bcr-2018-225231.27","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21423"},{"key":"2025042705441934000_2018.jul27_1.bcr-2018-225231.28","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-10-602607"},{"key":"2025042705441934000_2018.jul27_1.bcr-2018-225231.29","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.amjms.2017.04.016","article-title":"Significance of hyperferritinemia in hospitalized adults","volume":"354","author":"Schaffner","year":"2017","journal-title":"Am J Med Sci"},{"key":"2025042705441934000_2018.jul27_1.bcr-2018-225231.30","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s12185-009-0391-5","article-title":"Early diagnostic value of low percentage of glycosylated ferritin in secondary hemophagocytic lymphohistiocytosis","volume":"90","author":"Wang","year":"2009","journal-title":"Int J Hematol"},{"key":"2025042705441934000_2018.jul27_1.bcr-2018-225231.31","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/ijlh.12713","article-title":"Diagnostic and prognostic value of low percentage of glycosylated ferritin in acquired hemophagocytic lymphohistiocytosis: a single-center study","volume":"39","author":"Nabergoj","year":"2017","journal-title":"Int J Lab Hematol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2018-225231","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T12:44:34Z","timestamp":1745757874000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2018-225231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,30]]},"references-count":31,"alternative-id":["10.1136\/bcr-2018-225231"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2018-225231","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,30]]}}}